prof. Mgr. Vítězslav Bryja, Ph.D.
Department head, Department of Experimental Biology
correspondence Address:
Kotlářská 267/2, 611 37 Brno
office: bldg. D36/112
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 3291 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 218
2018
-
Promoter methylation of ROR1 ligand WNT5A associates with its expression in CLL
Year: 2018, type: Conference abstract
-
SEMIQUANTITATIVE ASSESSMENT OF DISHEVELLED-3 PHOSPHORYLATION STATUS BY MASS SPECTROMETRY
HUNGARIAN JOURNAL OF INDUSTRY AND CHEMISTRY, year: 2018, volume: 46, edition: 1, DOI
-
The planar cell polarity protein VANG-1/Vangl negatively regulates Wnt/beta-catenin signaling through a Dvl dependent mechanism
PLoS Genetics, year: 2018, volume: 14, edition: 12, DOI
2017
-
A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation
Frontiers in Cell and Developmental Biology, year: 2017, volume: 5, edition: MAY, DOI
-
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway
MOLECULAR NEURODEGENERATION, year: 2017, volume: 12, edition: 54, DOI
-
Angled Growth of the Dental Lamina Is Accompanied by Asymmetrical Expression of the WNT Pathway Receptor Frizzled 6
Frontiers in Physiology, year: 2017, volume: 8, edition: 29, DOI
-
Casein kinase 1 delta/epsilon inhibition blocks CLL chemotaxis and delays leukemia onset in the Eµ-TCL1 mouse model of chronic lymphocytic leukemia.
Year: 2017, type: Conference abstract
-
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status
LEUKEMIA & LYMPHOMA, year: 2017, volume: 58, edition: 1, DOI
-
Comparative cell cycle transcriptomics reveals synchronization of developmental transcription factor networks in cancer cells
PLOS ONE, year: 2017, volume: 12, edition: 12, DOI
-
Kompletní analýza vlastností nových inhibitorů kasein kinázy 1 pro léčbu chronické lymfocytární leukémie
Year: 2017, type: